Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats

Anesthesiology

Volumn 110, Issue 5, 2009, Pages 1077-1085

  Sanders, Robert D ^a   Xu, Jing ^c   Shu, Yi ^a   Januszewski, Adam ^a   Halder, Sunil ^a,b   Fidalgo, Antonio ^a   Sun, Pamela ^a   Hossain, Mahmuda ^a   Ma, Daqing ^a   Maze, Mervyn ^a,d,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Reading General Hospital   (United Kingdom)

^c Gongli Hospital   (China)

^d ABBOTT LABORATORIES   (United States)

^e CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID; ALPHA ADRENERGIC RECEPTOR; ATIPAMEZOLE; CASPASE 3; DEXMEDETOMIDINE; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG POTENTIATION; FUNCTIONAL ASSESSMENT; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEMORY DISORDER; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT TERM MEMORY; THALAMUS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; COGNITION DISORDERS; DEXMEDETOMIDINE; ISOFLURANE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 65549162169     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31819daedd     Document Type: Article

References (53)

1. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876-82
2. Hansen HH, Briem T, Dzietko M, Sifringer M, Voss A, Rzeski W, Zdzisinska B, Thor F, Heumann R, Stepulak A, Bittigau P, Ikonomidou C: Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 2004; 16:440-53
3. Lu LX, Yon JH, Carter LB, Jevtovic-Todorovic V: General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006; 11:1603-15
4. Ma D, Williamson P, Januszewski A, Nogaro MC, Hossain M, Ong LP, Shu Y, Franks NP, Maze M: Xenon mitigates isourane-induced neuronal apoptosis in the developing rodent brain. ANESTHESIOLOGY 2007; 106:746-53
5. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW: Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287:1056-60
6. Jain N, Florence SL, Qi HX, Kaas JH: Growth of new brainstem connections in adult monkeys with massive sensory loss. Proc Natl Acad SciUSA. 2000;97:5546-50
7. Hestrin S: Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 1992; 357:686-9
8. Hardingham GE, Bading H: The Yin and Yang of NMDA receptor signaling. Trends Neurosci 2003; 26:81-9
9. Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-14.
10. Yon JH, Daniel-Johnson J, Carter LB, Jevtovic-Todorovic V: Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005; 135:815-27
11. Olney JW, Young C, Wozniak DF, Ikonomidou C, Jevtovic-Todorovic V: Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? ANESTHESIOLOGY 2004; 101:273-5
12. Johnson SA, Young C, Olney JW: Isourane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 2008;20:21-8
13. Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, Labruyere J, Olney JW: Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 2005; 146:189-97
14. Winzer-Serhan UH, Leslie FM: Expression of alpha2A adrenoceptors during rat neocortical development. J Neurobiol 1999; 38:259-69
15. Song ZM, Abou-Zeid O, Fang YY: Alpha2a adrenoceptors regulate phosphorylation of microtubule-associated protein-2 in cultured cortical neurons. Neuroscience 2004; 123:405-18
16. Wang Q, Lu R, Zhao J, Limbird LE: Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 2006; 281:25948-55
17. Philipp M, Brede ME, Hadamek K, Gessler M, Lohse MJ, Hein L: Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo. Nat Genet 2002; 31:311-5
18. Engelhard K, Werner C, Eberspächer E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E: The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96:524-31
19. Dahmani S, Paris A, Jannier V, Hein L, Rouelle D, Scholz J, Gressens P, Desmonts JM, Mantz J: Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: Evidence for the involvement of imidazoline I1 receptors. ANESTHESIOLOGY 2008; 108:457-66
20. Dahmani S, Rouelle D, Gressens P, Mantz J: Effect of dexmedetomidine on brain derived neurotrophic factor expression in rat hippocampal slices (abstract). ANESTHESIOLOGY 2006; 105:A681
21. Gahwiler BH: Organotypic monolayer cultures of nervous tissue. J Neurosci Methods 1981; 4:329-42
22. Stoppini L, Buchs PA, Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37:173-82
23. Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. ANESTHESIOLOGY 2002; 96:1485-91
24. Quinn JJ, Loya F, Ma QD, Fanselow MS: Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hip-
25. pocampus 2005; 15:665-74
26. Ma D, Hossain M, Rajakumaraswamy N, Franks NP, Maze M: Combination of xenon and isourane produces a synergistic protective effect against oxygen-glucose deprivation injury in a neuronal-glial co-culture model. ANESTHESIOLOGY 2003; 99:748-51
27. Fanselow MS: Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Res 2000; 110:73-81
28. Sanders RD, Giombini M, Ma D, Ohashi Y, Hossain M, Fujinaga M, Maze M: Dexmedetomidine exerts dose-dependent age-independent antinociception but age-dependent hypnosis in Fischer rats. Anesth Analg 2003; 100:1295-302
29. Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Limbird LE: Substitution of a mutant alpha2a-adrenergic receptor via ǎæhit and runǎ gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad SciUSA 1997; 94:9950-5
30. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M: Dexmedetomidine produces its neuroprotective effect via the 2A-adrenoceptor subtype. Eur J Pharmacol 2004; 502:87-97
31. Dahmani S, Paris A, Hein L, Gressens P, Mantz J: Dexmedetomidine activates ERK1&2 via a non-2 adrenoceptors-mediated pathway (abstract). ANESTHESIOLOGY 2007:A12
32. Loepke AW, McCann JC, Kurth CD, McAuliffe JJ: The physiologic effects of isourane anesthesia in neonatal mice. Anesth Analg 2006; 102:75-80
33. Wise-Faberowski L, Zhang H, Ing R, Pearlstein RD, Warner DS: Isourane-induced neuronal degeneration: An evaluation in organotypic hippocampal slice cultures. Anesth Analg 2005; 101:651-7
34. Blum S, Hebert AE, Dash PK: A role for the prefrontal cortex in recall of recent and remote memories. Neuroreport 2005; 17:341-4
35. Slikker W Jr, Zou X, Hotchkiss CE, Divine RL, Sadovova N, Twaddle NC, Doerge DR, Scallet AC, Patterson TA, Hanig JP, Paule MG, Wang C: Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007;98:145-58
36. Elsersy H, Mixco J, Sheng H, Pearlstein RD, Warner DS: Selective gamma-aminobutyric acid type A receptor antagonism reverses isourane ischemic neuroprotection. ANESTHESIOLOGY 2006; 105:81-90
37. Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, Zaugg M, Vogt KE, Ledermann B, Antkowiak B, Rudolph U: General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J 2003; 17:250-2
38. Sonner JM, Zhang Y, Stabernack C, Abaigar W, Xing Y, Laster MJ: GABA(A) receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isourane in a dose-related manner. Anesth Analg 2003; 96:706-12
39. Cattano D, Young C, Olney J: Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain (abstract). ANESTHESIOLOGY 2007; 106:A1984
40. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M: The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002; 5:979-84
41. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, Eckenhoff RG: Isourane and sevourane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005; 1037:139-47
42. Satomoto M, Satoh Y, Terui K, Imaki J: Inhaled sevourane induces apoptosis in the developing brain and behavioural abnormality in mice (abstract). ANESTHESIOLOGY 2008; 109:A26
43. Marrs W, Kuperman J, Avedian T, Roth RH, Jentsch JD: Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats. Neuropsychopharmacology 2005; 30:1500-10
44. Nagata A, Nakao Si S, Nishizawa N, Masuzawa M, Inada T, Murao K, Miyamoto E, Shingu K: Xenon inhibits but N(2)O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices. Anesth Analg 2001; 92:362-8
45. Rajakumaraswamy N, Ma D, Hossain M, Sanders RD, Franks NP, Maze M: Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Neurosci Lett 2006; 409:128-33
46. Fredriksson A, Ponten E, Gordh T, Eriksson P: Neonatal exposure to a combination of N-methyl-D-Aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioural deficits. ANESTHESIOLOGY 2007; 107:427-36
47. Dobbing J, Sands J: Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3:79-83
48. Sanders RD, Ma D, Brooks P, Maze M: Balancing paediatric anaesthesia: Preclinical insights into analgesia, hypnosis, neuroprotection and neurotoxicity. Br J Anaesth 2008; 101:597-609
49. Anand KJS, Hickey PR: Pain and its effects in the human neonate and fetus. N Engl J Med 1987; 317:1321-29
50. Porter FL, Grunau RE, Anand KJ: Long-term effects of pain in infants. J Dev Behav Pediatr 1999; 20:253-61
51. Taddio A, Katz J, Ilersich AL, Koren G: Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997; 349:599-603
52. Sanders RD, Maze M: Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs 2007; 8:25-33
53. Bergendahl H, Lonnqvist PA, Eksborg S: Clonidine: An alternative to benzodiazepines for premedication in children. Curr Opin Anaesthesiol 2005;18:608-13